Drug Discovery and Development
Transforming data into defensible leads with computational and genomic foresight.
In Silico & Computational Chemistry Advisory:
AI-driven molecular docking, virtual screening, and predictive ADME/Tox to de-risk capital allocation pre-synthesis.
Discovery & Medicinal Chemistry:
Hit-to-lead (H2L), SAR studies, and scaffold hopping to strengthen non-infringing IP portfolios for both Small Molecules and Complex Peptides.
Discovery Biology & Screening:
Independent vetting of labs for assay reproducibility to eliminate systemic discovery failure in High-Potency and Large Molecule programs.
Genomic Target Identification:
Specialized oversight for Precision Medicine platforms, ensuring data integrity in biomarker discovery and genetic target validation.
